About
Vincent Ruland joined Versant in August 2025 as an Entrepreneur-in-Residence in Basel, supporting existing portfolio companies and new opportunities in Europe and North America. He previously was SVP, Head of R&D Strategy, Portfolio and Operations at Bayer Pharmaceuticals, and is a physician-scientist trained in neuropathology with an M.D. from the University of Münster and an M.Phil. from the University of Cambridge.
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures